On the 13th September 2017, leaders of the BigData@Heart consortium held their first public webinar to introduce and outline the objectives of the Big Data for Better Hearts project that was launched in March this year.
BigData@Heart is funded by the Innovative Medicines Initiative (IMI), a public-private partnership between the European Union and the European pharmaceutical industry, and is part of their Big Data for Better Outcomes (BD4BO) research programme. The project is supported by a budget of € 19 million and will run for 5 years. The consortium consists of 19 stakeholders, including the European Society of Cardiology (ESC), numerous European academic research groups, and the European Federation of Pharmaceutical Industries and Associations (EFPIA). They will be working collectively under the IMI2 funding scheme, with the aim of applying big data approaches to improve patient outcomes in the most common cardiovascular diseases in Europe today: acute coronary syndrome, atrial fibrillation and heart failure. Read more...